Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.
Gut Microbiota Linked to Sexual Preference and HIV Infection.
Population pharmacokinetic modelling of the changes in atazanavir plasma clearance caused by ritonavir plasma concentrations in HIV-1 infected patients.
Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8 years of follow-up.
Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity.
Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial.
Nitrogen positional scanning in tetramines active against HIV-1 as potential CXCR4 inhibitors.
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
Management of bone mineral density in HIV-infected patients.
Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease.